LyfeBulb

Name

LyfeBulb

Legal name

Lyfebulb Holdings Inc.

Website

https://lyfebulb.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Patient Engagement Services

NAICS

Other Individual and Family Services (624190), Social Assistance (624)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Patient engagement platform
• Chronic disease communities
• Healthcare innovation challenges
• Patient advocacy networks
• Disease-specific digital platforms

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Innovation Challenge Sponsorships: Lyfebulb partners with pharmaceutical companies, health plans, and healthcare companies as sponsors who pay to source patient-driven innovation through organized challenge events. These partnerships provide access to patient communities and insights.
2. Healthcare Industry Partnerships: Bridges gap between patient communities and healthcare industry by working with sponsors looking to solve intelligent and critical problems for their patient community. Revenue generated through partnership arrangements with pharma companies and health plans.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Core offering

Lyfebulb is a patient engagement platform that bridges chronic disease patient communities with the healthcare industry. It operates disease-specific digital community platforms (TransplantLyfe, IBDLyfe, CancerLyfe, KidneyLyfe), runs sponsored Innovation Challenges for pharmaceutical and healthcare sponsors, and delivers patient engagement services including workshops, interviews, user testing, surveys, and insight mapping across eleven chronic disease areas.

Product overview

Lyfebulb is a patient engagement and innovation accelerator platform that connects patient communities with the healthcare industry. The company operates across eleven chronic disease areas and offers a portfolio of disease-specific digital platforms (TransplantLyfe, IBDLyfe, CancerLyfe, KidneyLyfe) alongside community programs including the Ambassador Program, Entrepreneur Circle, and Innovation Challenges. These products work together to engage patients, generate insights, and drive patient-driven innovation in healthcare.

Differentiator

Problem solved

Functional benefit

Brands

• TransplantLyfe: Digital platform for transplant patients and care partners
• IBDLyfe
• CancerLyfe
• KidneyLyfe

Products and services

• TransplantLyfe A digital platform providing resources, community connection, webinars, and support for transplant patients and care partners, including the TransplantLyfe365 mobile app.
• IBDLyfe A digital community platform dedicated to supporting patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.
• CancerLyfe A digital platform supporting cancer patients through their journey, including rare cancer support via RareCancerLyfe.
• KidneyLyfe A digital community empowering patients with chronic kidney disease and dialysis through connection, education, and peer support.
• Innovation Challenges Partnered innovation competitions that connect patient entrepreneurs with healthcare industry sponsors to source and fund patient-driven solutions across various disease areas, culminating in pitch competitions judged by expert panels.
• Patient Engagements Direct collaboration with patients and care partners through workshops, interviews, user testing, surveys, and research to generate insights and build impactful solutions for healthcare industry partners.

Quantifiable outcome

• Over 11 innovation challenges conducted with pharmaceutical and healthcare sponsors
• +2 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

15 partnerships are on record, tiered flagship, core and minor.

• Patient Care AmericaflagshipOthers · 5 March 2024Patient Care America announced acquisition of Lyfebulb in March 2024, combining resources to create a premier patient-focused renal solutions provider. Lyfebulb is now a Patient Care America business according to terms and conditions documentation.
• J.P. Morgan Life Sciences Private CapitalflagshipGTM or Marketing Partner · 16 November 2023J.P. Morgan Life Sciences Private Capital partnered with Lyfebulb to sponsor the inaugural Life Sciences Innovation Summit at Cleveland Clinic Abu Dhabi in May 2024. The summit aimed to attract early-stage entrepreneurs in life sciences to seed growth of the emerging scientific innovation hub in Abu Dhabi. 11 emerging companies were invited to pitch to an industry-renowned judging panel with potential for J.P. Morgan Life Sciences Private Capital support.
• Blue Horizon AdvisorsflagshipGTM or Marketing Partner · 16 November 2023Blue Horizon Advisors, the independent private investment arm of a UAE family office, established a Life Sciences vertical (BHLS) and partnered with Lyfebulb as co-sponsor of the Life Sciences Innovation Summit in Abu Dhabi. Committed to becoming a prominent force within the MENA region's life sciences sector through strategic acquisitions, joint ventures, and collaborations.
• United AlSaqer GroupcoreGTM or Marketing Partner · 16 November 2023United AlSaqer Group joined as co-sponsor of the J.P. Morgan Asset Management Life Sciences Innovation Summit at Cleveland Clinic Abu Dhabi, supporting the growth of the Abu Dhabi life sciences innovation ecosystem.
• Bristol Myers SquibbflagshipGTM or Marketing Partner · 20 September 2022Bristol Myers Squibb partnered with Lyfebulb for the 2022 Global Innovation Challenge addressing unmet needs in IBD. The challenge sourced innovative ideas and scalable solutions for better disease management and care, culminating in pitch competition with $50,000 in prizes ($25,000 Innovation Award + $25,000 Impact Award).
• Veloxis PharmaceuticalsflagshipGTM or Marketing Partner · 26 July 2022Veloxis Pharmaceuticals sponsored the 2022 Innovation Challenge: Transforming Organ Transplantation held at their headquarters in Cary, North Carolina. The challenge sought solutions for transplant patient care with $40,000 in prizes ($25,000 Innovation Award + $15,000 Impact Award). Veloxis also sponsors a transplant education series with Lyfebulb and Columbia University.
• Columbia University/NewYork-Presbyterian HospitalcoreStrategic or Co-development Partner · 1 January 2022Lyfebulb partnered with Columbia University and NewYork-Presbyterian Hospital for transplant patient education series. Veloxis Pharmaceuticals sponsors this transplant education series in partnership with Lyfebulb and Columbia, with webinars available on TransplantLyfe platform.
• Chris Klug FoundationminorStrategic or Co-development Partner · 1 January 2022Lyfebulb partnered with the Chris Klug Foundation, participating in their Women in Transplant initiative to support and empower women in the transplant community.
• CVS Kidney CareflagshipGTM or Marketing Partner · 1 November 2021CVS Kidney Care partnered with Lyfebulb for the 2022 Innovation Challenge focused on accelerating innovations in kidney disease to improve health equity and outcomes. The inaugural challenge addressed health disparities among CKD and ESRD patients, awarding $25,000 to OmniLife. Partnership built upon shared commitment to advancing patient-driven innovation.
• Loyola University Chicago Parkinson School of Health Sciences and Public HealthflagshipStrategic or Co-development Partner · 2 August 2021Loyola University Chicago's Parkinson School partnered with Lyfebulb for the 2021 Innovation Challenge: Meeting Our Moment - Reimagining Innovation, Improving Health Equity, and Building Resiliency. A virtual summit addressing effects of emerging infectious diseases on population health, healthcare delivery, and health equity. $75,000 distributed among up to three winners, funded by Bob and Betty Parkinson endowment.
• Arena PharmaceuticalsflagshipGTM or Marketing Partner · 8 April 2021Arena Pharmaceuticals sponsored the 2021 Imagining Life Without Limits - An Inflammatory Bowel Disease Innovation Challenge. The virtual challenge sought solutions to better equip IBD patients with tools to manage disease and improve quality of life. $25,000 Innovation Award presented to Coral Genomics.
• CSL BehringcoreGTM or Marketing Partner · 1 January 2021CSL Behring partnered with Lyfebulb for the 2021 Innovation Challenge: Thriving with Transplantation. Celebratory conversation events and innovation challenge to support transplant patients and care partners.
• HelsinncoreGTM or Marketing Partner · 1 January 2021Helsinn partnered with Lyfebulb for the second annual Patient-Driven Innovation Summit in Cancer. Award presented to Patient Entrepreneur demonstrating outstanding science and potential to bring cancer and cancer supportive care solutions to market.
• Crohn's & Colitis FoundationminorStrategic or Co-development Partner · 1 January 2021Crohn's & Colitis Foundation participated in the IBD Innovation Challenge as judges and advisors, contributing expertise to evaluate patient-driven innovations for inflammatory bowel disease.
• OrexocoreGTM or Marketing Partner · 1 January 2020Orexo partnered with Lyfebulb for the 2020 Innovation Challenge in Substance Use Disorders. Challenge recognized Patient Entrepreneurs with solutions aiding successful, long-term recovery from alcohol and opioid use disorders, with $25,000 grant for the winning finalist.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lyfebulb
• Facebookfacebook.com/Lyfebulb
• Instagraminstagram.com/lyfebulb
• LinkedInlinkedin.com/company/lyfebulb

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LyfeBulb